Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02367235 · ClinicalTrials.gov registry record · NA

Analysis of Procedural Times Using Colpassist for Robotic-Assisted Sacrocolpopexy; a Randomized Controlled Trial

A NA study of Pelvic Organ Prolapse, sponsored by University of North Carolina, Chapel Hill.

Completed
Registry status
NA
Development phase
52
Enrollment target
1
Study location

NCT02367235 is a NA study of Pelvic Organ Prolapse that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 52 participants, below the 144-participant average among 40 other Pelvic Organ Prolapse trials with a reported enrollment target (64% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02367235, a NA study of Pelvic Organ Prolapse, has completed, sponsored by University of North Carolina, Chapel Hill.

COMPLETED
Registry status
NA
Development phase
52 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to evaluate the efficiency of the Colpassist vaginal positioning device during robotic-assisted sacrocolpopexy.

Conditions Studied

Interventions

  • PROCEDURE Traditional vaginal positioning device
  • PROCEDURE Colpassist vaginal positioning device

Study Locations (1)

North Carolina

  • University of North Carolina, Chapel Hill - Female Pelvic Medicine and Reconstructive Surgery - Chapel Hill

Trial Details

FieldValue
Enrollment Target 52 participants
Start Date 2015-01
Est. Completion 2018-04
Phase NA

What the Registry Record Tells You About NCT02367235

The ClinicalTrials.gov registry entry for NCT02367235 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 52 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 144-participant average among 40 other Pelvic Organ Prolapse trials with a reported enrollment target (64% lower). The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Pelvic Organ Prolapse appearing as the primary indexed condition, and to 2 interventions - of which Traditional vaginal positioning device is the first listed.

NCT02367235 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT02367235 about?

NCT02367235 is a clinical study titled "Analysis of Procedural Times Using Colpassist for Robotic-Assisted Sacrocolpopexy; a Randomized Controlled Trial". The purpose of this study is to evaluate the efficiency of the Colpassist vaginal positioning device during robotic-assisted sacrocolpopexy.

What is the current status of trial NCT02367235?

This trial is currently completed. It is a NA study. The enrollment target is 52 participants. The study started on 2015-01. Estimated completion is 2018-04.

What conditions does trial NCT02367235 study?

This clinical trial studies the following conditions: Pelvic Organ Prolapse.

What interventions are being tested in trial NCT02367235?

The interventions under investigation include: Traditional vaginal positioning device (PROCEDURE), Colpassist vaginal positioning device (PROCEDURE).

Who is sponsoring clinical trial NCT02367235?

This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02367235 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pelvic Organ Prolapse

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.